Identification of miR-589-5p as a Potential Prognostic Biomarker of Hepatocellular Carcinoma
Abstract Background: MicroRNAs (miRNAs) are small endogenous non-coding RNAs with 22 nucleotides approximately. Numerous studies have reported that microRNAs may hold the potential to serve as biomarkers in diagnosing cancer and predicting prognosis. miR-589-5p is a well-documented oncogenic miRNA implicated in several human cancer types. However, the potential value of miR-589-5p as a biomarker to facilitate early diagnosis and predict prognosis in hepatocellular carcinoma (HCC) patients remains obscure.Methods: miR-589-5p expression was examined by in situ hybridization (ISH) in 10 adjacent normal tissues (ANT), 21 liver fibrosis tissues, 113 HCC tissues, including 22 HCC with grade I, 37 HCC with grade II, 49 HCC with grade III and 5 hepatocholangiocellular carcinoma tissues. Statistical analysis and Kaplan–Meier survival analysis was performed to evaluate the clinical correlation between miR-589-5p expression and clinicopathological features and survival prognosis in HCC patients.Results: miR-589-5p expression was dramatically upregulated in HCC tissues by in situ hybridization (ISH). Overexpression of miR-589-5p was not only positively correlated with poor tumor differentiation degree, increased AFP levels, advanced clinical stage, distant metastatic status and venous invasion, but also predicted poor overall and relapse-free survival in HCC patients. Importantly, the expression levels of miR-589-5p measured by real-time PCR in high-ISH scores tissues were dramatically upregulated compared with those in low-ISH scores tissues, and a strong and positive correlation of miR-589-5p expression levels in real-time PCR with ISH staining index was demonstrated in HCC tissues.Conclusion: our results support the notion that miR-589-5p might hold a promising value as a novel biomarker to facilitate early diagnosis and predict prognosis in HCC patients.